Exhalation Delivery Systems for Application of Intranasal Corticosteroids.

Alexander J KovacsAlexander J KovacsEdward C Kuan

Published in: Ear, nose, & throat journal (2020)

Exhalation delivery system with fluticasone demonstrates significant results in both patient-oriented outcomes and objective measures of sinonasal inflammation in patients with CRS with and without polyps. Further research is needed to investigate the long-term outcomes of EDS-FLU and to compare the effects of EDS-FLU with ESS. Exhalation delivery system with fluticasone provides an additional effective treatment modality for patients suffering from CRS.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
metabolic syndrome
insulin resistance